Connect with us

Technology

Laboratory Automation Systems Market size is set to grow by USD 2.01 billion from 2024-2028, Increasing demand for laboratory automation software services boost the market, Technavio

Published

on

NEW YORK, July 31, 2024 /PRNewswire/ — The global laboratory automation systems market size is estimated to grow by USD 2.01 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 8.68%  during the forecast period. Increasing demand for laboratory automation software services is driving market growth, with a trend towards rising number of FDA-approved manufacturing facilities in developing nations. However, lack of adoption of automated solutions by small-scale and medium-scale laboratories  poses a challenge. Key market players include Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Bee Robotics Ltd., Biosero Inc., Cognex Corp., Eppendorf SE, F. Hoffmann La Roche Ltd., Gilson Inc., LabVantage Solutions Inc., LabWare Inc., Olympus Corp., PerkinElmer Inc, QIAGEN NV, SCINOMIX, Siemens AG, SPT Labtech Ltd., Tecan Trading AG, and Thermo Fisher Scientific Inc..

Get a detailed analysis on regions, market segments, customer landscape, and companies- View the snapshot of this report

Laboratory Automation Systems Market Scope

Report Coverage

Details

Base year

2023

Historic period

2018 – 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 8.68%

Market growth 2024-2028

USD 2.01 billion

Market structure

Fragmented

YoY growth 2022-2023 (%)

8.26

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 42%

Key countries

US, Germany, UK, China, and Japan

Key companies profiled

Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Bee Robotics Ltd., Biosero Inc., Cognex Corp., Eppendorf SE, F. Hoffmann La Roche Ltd., Gilson Inc., LabVantage Solutions Inc., LabWare Inc., Olympus Corp., PerkinElmer Inc, QIAGEN NV, SCINOMIX, Siemens AG, SPT Labtech Ltd., Tecan Trading AG, and Thermo Fisher Scientific Inc.

Market Driver

The outsourcing of medical device manufacturing and drug discovery is a significant trend in the healthcare industry, driven by the need for US FDA-approved facilities, skilled labor at reasonable costs, and adherence to World Health Organization-Good Manufacturing Practice (WHO-GMP) standards. India is an attractive destination for healthcare contract research outsourcing due to its large number of US FDA-approved manufacturing plants, a talented workforce, and cost advantages. The implementation of product patents under the World Trade Organization Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement in 2005 further fueled outsourcing from developed markets. With the increasing demand for high-volume product orders, developing countries are investing in infrastructure and expertise, leading to the growth of the global laboratory automation systems market. The availability of efficient and cost-effective drug discovery in these countries is also contributing to market expansion during the forecast period. 

Laboratory automation systems are trending in the scientific community due to their ability to increase productivity, ensure safe working conditions, and provide reliable results in less time and effort. Integrated systems are becoming the norm, addressing issues like sample contamination and streamlining workflows. Automation dependence is growing, with robots restocking shelves and handling samples, while wireless connectivity enables seamless data transfer. High-throughput compound screening and fragment screening are key applications, with computer modeling and machine learning aiding potential therapeutic candidates’ discovery. FDA clearance is crucial for life-saving medical equipment, while precision medicine development relies on automated instruments for process automation. Sample handling, verifications, and labeling tubes are essential components, ensuring accurate results. Manufacturing machinery benefits from automation, reducing costs and improving efficiency. Immersive experiences and wireless connectivity enhance the user experience, making laboratory automation technology an indispensable tool for clinical laboratories. 

Discover 360° analysis of this market. For complete information, schedule your consultation – Book Here!

Market Challenges

Small- and medium-scale laboratories typically handle a lower volume of samples and focus on specific applications, such as diagnosis and testing of biological samples. Due to limited budgets, staff, and planning, automation is not a priority for these laboratories. Additionally, they often lack the necessary floor space for large-scale automation systems. In contrast, large-scale facilities can afford advanced automated solutions for processes like chemically relevant compound profiling, high-content screening, and large-scale cell culture development. However, small- and medium-scale laboratories are hesitant to invest in these technologically advanced products due to high maintenance and service costs related to laboratory informatics solutions. The lack of knowledge among professionals managing these laboratories regarding the benefits of automation further hinders adoption. These factors limit the growth of the global laboratory automation systems market during the forecast period.The Laboratory Automation Systems market is witnessing significant growth due to the increasing demand for automated solutions in various industries such as healthcare, food safety, and research. However, challenges persist in this market, including physical strain on lab personnel, miniaturization requirements in microbiology and biotechnology, and the need for accurate data analysis in clinical chemistry. To address these challenges, automated systems are being adopted for tasks like liquid handling, data management, and sample preparation. Government legislation, regulatory requirements, and budget constraints are also driving the market for automated systems. The total automation segment, including automated workstations and robotic systems, is experiencing high demand, especially in diagnostics, drug discovery, genomics, and proteomics. Customization services are essential to meet the unique needs of laboratories, whether high volume or specialized in forensics or healthcare applications. The market is expected to continue growing, offering benefits such as reduced repetitiveness, human intervention, time cycle, and improved data quality.

For more insights on driver and challenges – Request a sample report!

Segment Overview 

This laboratory automation systems market report extensively covers market segmentation by  

End-user 1.1 Pharmaceutical and biotechnology companies1.2 Clinical and reference laboratories1.3 Academic institutions and research organizations1.4 OthersType 2.1 Equipment2.2 Software2.3 servicesGeography 3.1 North America3.2 Europe3.3 Asia3.4 Rest of World (ROW)

1.1 Pharmaceutical and biotechnology companies-  Pharmaceutical and biotechnology companies are increasingly utilizing laboratory automation systems for high-content screening (HCS) applications in their drug discovery processes. Automated liquid handling systems are commonly used for screening clinically relevant compounds, isolating those with specific properties, and quantifying and analyzing screening assays. These systems can operate for extended periods with minimal supervision, enabling companies to focus on their core work and reduce time spent on repetitive tasks. Innovations like integrating analytical systems with software programs expedite the process and make it cost-effective. Longer runtimes and larger system sizes are further driving adoption. The emergence of new pharmaceutical and biotech firms focusing on novel drugs and molecular therapies is fueling market growth in this sector during the forecast period.

For more information on market segmentation with geographical analysis including forecast (2024-2028) and historic data (2017-2021) – Download a Sample Report

Research Analysis

Laboratory Automation Systems (LAS) are technological solutions designed to automate various laboratory processes, enhancing productivity, ensuring safe working conditions, and delivering reliable results. LAS encompasses automation of process steps such as sample handling, liquid handling, high throughput analysis, clinical chemistry analysis, and immunoassay analysis. These systems enable advanced data management, reduced human intervention, and total automation in segments like healthcare applications, clinical laboratories, diagnostic laboratories, and research institutions. Automated workstations and robotic systems are integral components of LAS, streamlining sample preparation and data analysis. LAS plays a pivotal role in improving laboratory efficiency, reducing errors, and ensuring consistent and accurate results.

Market Research Overview

Laboratory automation refers to the use of technology to automate various processes in laboratories, including the use of automated instruments for sample handling, verifications, labeling tubes, and data analysis. This technology offers numerous benefits, such as increased productivity, safe working conditions, reliable results, and reduced time and effort. Automated systems are used extensively in clinical laboratories, microbiology, biotechnology, clinical chemistry, and immunoassay analysis, among others. The market for laboratory automation systems is driven by the need for efficient and accurate laboratory processes, regulatory requirements, and government legislation. Automation enables reduction of repetitiveness and human intervention, resulting in enhanced workflow scope, reduced time cycle, and improved data quality. Automated liquid handlers, sample preparation, and data management are key components of laboratory automation systems. Miniaturization and immersive experience are emerging trends, with wireless connectivity and robots restocking shelves adding to the convenience. End users in the healthcare sector, including hospitals and diagnostic laboratories, are major consumers of laboratory automation systems. Budget constraints and emerging countries present opportunities for growth in the market. The diagnostics segment, including drug discovery, genomics solutions, proteomics solutions, and forensic laboratories, is a significant contributor to the market. Automated workstations, off-the-shelf automated workcells, and robotic systems are popular solutions. The total automation segment, with customization services, is gaining popularity due to the increasing complexity of laboratory needs. High volume laboratories, tables and accessories, and healthcare applications are other areas of focus. Laboratory automation systems offer significant benefits, including reduced repetitiveness, increased productivity, and improved data quality. However, challenges such as sample contamination, automation dependence, and FDA clearance must be addressed to ensure the success of these systems. Machine learning, InsilicoMedicine, and precision medicine development are emerging areas of application for laboratory automation systems. The potential therapeutic candidates identified through high-throughput compound screening and fragment screening offer significant opportunities for advancements in healthcare and manufacturing machinery.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

End-userPharmaceutical And Biotechnology CompaniesClinical And Reference LaboratoriesAcademic Institutions And Research OrganizationsOthersTypeEquipmentSoftwareServicesGeographyNorth AmericaEuropeAsiaRest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/laboratory-automation-systems-market-size-is-set-to-grow-by-usd-2-01-billion-from-2024-2028–increasing-demand-for-laboratory-automation-software-services-boost-the-market-technavio-302210040.html

SOURCE Technavio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Prime Minister to travel to New York City to attend the United Nations General Assembly and the Summit of the Future

Published

on

By

OTTAWA, ON, Sept. 16, 2024 /CNW/ – The Prime Minister, Justin Trudeau, today announced that he will travel to New York City, United States of America, from September 22 to 25, 2024, to participate in the 79th Session of the United Nations General Assembly and the Summit of the Future. The Prime Minister will work closely with Canada’s international partners to strengthen democracy, take climate action, defend global security, and improve access to health care, including reproductive health.

As Co-Chair of the United Nations Sustainable Development Goals Advocates group, the Prime Minister will reaffirm Canada’s commitment to advancing ambitious international action toward the 2030 Agenda for Sustainable Development. This includes moving forward on shared work on education, climate change and biodiversity loss, and gender equality around the world.

At the Summit of the Future, the Prime Minister will join other leaders to take action on key global challenges and enhance ways to work together to secure a better future for everyone. The leaders will work to accelerate efforts on pressing global challenges, including sustainable development, international peace and security, technological innovation and digital co-operation, decarbonization and clean energy, and human rights.

Prime Minister Trudeau will co-host a discussion with the Prime Minister of Haiti, Garry Conille, to help mobilize the resources needed to address the crises the country is facing and support solutions that are Haitian-led and focused on the needs of the Haitian people. He will also co-host a high-level event with the President of the European Commission, Ursula von der Leyen, to promote action on climate change, carbon pricing, and industrial decarbonization.

Throughout his visit, the Prime Minister will collaborate with other leaders on pressing geopolitical challenges, including Russia’s ongoing war of aggression against Ukraine as well as the evolving situation in the Middle East. He will emphasize the importance of international efforts to safeguard peace and security around the world, including by defending democracy and strengthening the rules-based international order.

Achieving a more peaceful, stable, and prosperous world starts with unified global action. Canada’s unwavering commitment to the United Nations is a pledge to Canadians that we will do our part to build a better future for everyone.

Quote
“At this year’s United Nations General Assembly and at the Summit of the Future, Canada will have a leading role in making the world fairer and more prosperous. I look forward to working with other leaders to accelerate progress on our shared priorities and build a better future for everyone.”
— The Rt. Hon. Justin Trudeau, Prime Minister of Canada

Quick Facts

Canada has been active at the United Nations (UN) since its creation in 1945 and has played a key role in drafting the UN Charter, the treaty that is the cornerstone of the rules-based international order.Canada is the sixth-largest donor to the UN, including voluntary and assessed contributions totalling over US$2 billion in 2022.In 2015, Canada joined all UN Member States in adopting ambitious goals for sustainable development, as outlined in Transforming our World: The 2030 Agenda for Sustainable Development. The 2030 Agenda centres on a set of 17 Sustainable Development Goals (SDGs), encompassing the social, economic, and environmental dimensions of sustainable development. Taken together, the SDGs aim to improve the lives of all people, while protecting the planet.Released in 2021, Moving Forward Together: Canada’s 2030 Agenda National Strategy builds upon 30 actions and five core principles to create and foster an enabling environment for ongoing dialogue and participation to encourage Canadians to take action to realize the SDGs.In 2022, Prime Minister Trudeau was named Co-Chair, with the Prime Minister of Barbados, Mia Mottley, of the UN SDG Advocates group by UN Secretary-General António Guterres. SDG Advocates work to raise global awareness of the SDGs and of the need for accelerated action by using their respective platforms.In 2021, Canada launched the Global Carbon Pricing Challenge. This partnership aims to expand the use of pollution pricing by strengthening existing systems and supporting emerging ones. The Challenge also serves as a forum for dialogue and co-ordination to make pricing systems more effective and compatible while supporting other countries in adopting carbon pricing and cutting emissions on the path to net-zero by 2050.

Associated Links

Canada and the United NationsSummit of the FutureTransforming our World: The 2030 Agenda for Sustainable DevelopmentThe 2030 Agenda for Sustainable Development

This document is also available at https://pm.gc.ca

SOURCE Prime Minister’s Office

Continue Reading

Technology

NORTH STAR PROMISE DRIVES RECORD ENROLLMENT AT MINNESOTA’S PUBLIC COLLEGES AND UNIVERSITIES

Published

on

By

State Colleges and Universities See 7% Enrollment Surge; University of Minnesota Freshman Class Up 8%

SAINT PAUL, Minn., Sept. 16, 2024 /PRNewswire/ — North Star Prosperity released the following statement after public higher education institutions across the state reported a surge in enrollment thanks to the North Star Promise, a groundbreaking program designed to increase college access and affordability by providing tuition-free opportunities at public and tribal colleges for Minnesota residents making less than $80,000. It is the first time in over a decade that enrollment at Minnesota’s public colleges has increased.

North Star Prosperity led the campaign for North Star Promise, which Governor Tim Walz signed into law in May 2023.

“The North Star Promise program is a game-changer,” stated Mike Dean, Executive Director of North Star Prosperity. “We know that higher education is the most reliable path toward the middle class and yet for more than two decades, the cost of college has been out of reach for too many students. When we make education affordable and accessible, it’s an investment in the future of Minnesota’s workforce. Giving Minnesotans the tools to succeed in today’s economy is not only the right thing to do; it’s good business.”

For more information about the North Star Promise and how it benefits Minnesota residents, please visit www.northstarprosperity.org/freecollege or contact Mike Dean.

North Star Prosperity is fighting for an economy that works for all Minnesotans. Driven by our belief that everyone deserves a fair shot, we challenge the systemic roots of poverty and inequality by advocating for progressive economic policies that dismantle structural barriers and expand opportunity for all.

View original content to download multimedia:https://www.prnewswire.com/news-releases/north-star-promise-drives-record-enrollment-at-minnesotas-public-colleges-and-universities-302249333.html

SOURCE North Star Prosperity

Continue Reading

Technology

Mynaric Advances Production of CONDOR Mk3

Published

on

By

Shipments will support the Space Development Agency’s Tranche 1 program

MUNICH, Sept. 16, 2024 /PRNewswire/ —  Mynaric (NASDAQ: MYNA) (FRA: M0YN), a leading provider of industrialized, cost-effective and scalable laser communications products, today announced the successful advancement of the company’s volume production ramp for the CONDOR Mk3. Mynaric continues to work through previously announced production delays and has realized near-term improvement in production yields and supply chain-related bottlenecks. Production delays of CONDOR Mk3 were caused by lower than expected production yields and supplier shortages of key components.

“We remain committed to our mission to deliver laser communications products at scale to the market and meet our near-term customer requirements,” said Joachim Horwath, Chief Technology Officer and founder of Mynaric. “Despite the setbacks we faced over the past few months, our team has worked tirelessly to address these challenges. We have implemented solutions to ensure the smooth continuation of our production process.”

“We are happy to report that the technical challenges on the production ramp are being addressed and I am working with Joachim to ensure that Mynaric is well positioned for future success,” said Andreas Reif, Chief Restructuring Officer of Mynaric. “Moving forward, Mynaric will continue to meet the current requirements of our customers.”

Current shipments of the CONDOR Mk3 free space optical communications system will be part of the United States Space Development Agency (SDA) Tranche 1 program. Mynaric was selected by Northrop Grumman as the sole supplier of optical communications terminals for the SDA’s Tranche 1 Transport and Tracking Layer programs and by York Space Systems for the SDA’s Tranche 1 Transport Layer. Mynaric was also selected by Loft Federal to supply the CONDOR Mk3 terminals to NExT – the SDA’s Experimental Testbed.

In addition, Mynaric continues to pursue opportunities that explore the use of free-space optical communications for additional space programs. Mynaric has been recognized as a key development partner in Phase 2 of DARPA’s Space-BACN program, was selected by the European Space Agency (ESA) to investigate optical technologies for next generation high-throughput optical inter-satellite links and was selected by the German government for multiple projects to develop quantum communication capabilities.

In addition, Mynaric continues to diligently pursue additional capital sources to secure our on-going operations and production ramp. We continue to evaluate a number of different strategic options to address our near-term capital needs.

About Mynaric

Mynaric (NASDAQ: MYNA) (FRA: M0YN) is leading the industrial revolution of laser communications by producing optical communications terminals for air, space and mobile applications. Laser communication networks provide connectivity from the sky, allowing for ultra-high data rates and secure, long-distance data transmission between moving objects for wireless terrestrial, mobility, airborne- and space-based applications. The company is headquartered in Munich, Germany, with additional locations in Los Angeles, California, and Washington, D.C.

For more information, visit mynaric.com

MEDIA CONTACT
Krista Hazen                                                                                   
krista.hazen@mynaricusa.com   

View original content to download multimedia:https://www.prnewswire.com/news-releases/mynaric-advances-production-of-condor-mk3-302249337.html

SOURCE Mynaric USA, Inc.

Continue Reading

Trending